Page last updated: 2024-09-04

olmesartan and Cardiomyopathies

olmesartan has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Komuro, I; Mizukami, M; Oka, T; Sakamoto, M; Sano, M; Sugaya, T; Toko, H; Yamamoto, R; Zou, Y	1

Other Studies

1 other study(ies) available for olmesartan and Cardiomyopathies

Article	Year
Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cardiomyopathies; Cytoplasm; Doxorubicin; Gene Expression; Heart; Imidazoles; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Myofibrils; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; Tetrazoles; Vacuoles	2002

Article

Year

Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy.

Hypertension research : official journal of the Japanese Society of Hypertension, 2002, Volume: 25, Issue:4

Topics: Angiotensin Receptor Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cardiomyopathies; Cytoplasm; Doxorubicin; Gene Expression; Heart; Imidazoles; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Myofibrils; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; Tetrazoles; Vacuoles

2002